Courtagen Life Sciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile
- GDPH232590D
- Pages: 22
- July 2017
- Total Views:1154
- Region : North America
- GlobalData
- Equity Research Report

Details
Summary
Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company's products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen's products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headquartered in Woburn, Massachusetts, the US.
Courtagen Life Sciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11
Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12
Partnerships 12
Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12
Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14
Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15
Acquisition 15
Courtagen Life Sciences Acquires Medicinal Genomics 15
Courtagen Life Sciences Inc-Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Feb 17, 2017: Courtagen Launches New Avantra Genetics Division to Provide Personalized Genetic Information for Functional Medicine 20
Corporate Communications 21
Jan 21, 2016: Courtagen Life Sciences Receives New York State Clinical Laboratory Approval 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List Of Figure
List of Figures
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
List Of Table
List of Tables
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11
Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12
Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12
Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14
Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15
Courtagen Life Sciences Acquires Medicinal Genomics 15
Courtagen Life Sciences Inc, Key Competitors 17
Courtagen Life Sciences Inc, Key Employees 18
Courtagen Life Sciences Inc, Subsidiaries 19
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Courtagen Life Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company's products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen's products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headquartered in Woburn, Massachusetts, the US.
Courtagen Life Sciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11
Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12
Partnerships 12
Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12
Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14
Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15
Acquisition 15
Courtagen Life Sciences Acquires Medicinal Genomics 15
Courtagen Life Sciences Inc-Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Feb 17, 2017: Courtagen Launches New Avantra Genetics Division to Provide Personalized Genetic Information for Functional Medicine 20
Corporate Communications 21
Jan 21, 2016: Courtagen Life Sciences Receives New York State Clinical Laboratory Approval 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List Of Figure
List of Figures
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
List Of Table
List of Tables
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 1
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Courtagen Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 11
Courtagen Life Sciences Secures USD8 Million In Series B Venture Financing 12
Courtagen Life Sciences Enters into Agreement with Astellas Pharma 12
Courtagen Life Sciences Enters into Agreement with Connecticut Children's Medical Center 13
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 14
Courtagen Life Sciences Enters Into Co-Development Agreement With Avaxia Biologics To Evaluate Oral Antibody For Radiation Damage 15
Courtagen Life Sciences Acquires Medicinal Genomics 15
Courtagen Life Sciences Inc, Key Competitors 17
Courtagen Life Sciences Inc, Key Employees 18
Courtagen Life Sciences Inc, Subsidiaries 19
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Courtagen Life Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.